UniProt ID | PKN2_HUMAN | |
---|---|---|
UniProt AC | Q16513 | |
Protein Name | Serine/threonine-protein kinase N2 | |
Gene Name | PKN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 984 | |
Subcellular Localization | Cytoplasm . Nucleus . Membrane . Cell projection, lamellipodium . Cytoplasm, cytoskeleton . Cleavage furrow . Midbody . Cell junction . Colocalizes with PTPN13 in lamellipodia-like structures, regions of large actin turnover. Accumulates during telop | |
Protein Description | PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. Involved in the negative regulation of ciliogenesis. [PubMed: 27104747] | |
Protein Sequence | MASNPERGEILLTELQGDSRSLPFSENVSAVQKLDFSDTMVQQKLDDIKDRIKREIRKELKIKEGAENLRKVTTDKKSLAYVDNILKKSNKKLEELHHKLQELNAHIVVSDPEDITDCPRTPDTPNNDPRCSTSNNRLKALQKQLDIELKVKQGAENMIQMYSNGSSKDRKLHGTAQQLLQDSKTKIEVIRMQILQAVQTNELAFDNAKPVISPLELRMEELRHHFRIEFAVAEGAKNVMKLLGSGKVTDRKALSEAQARFNESSQKLDLLKYSLEQRLNEVPKNHPKSRIIIEELSLVAASPTLSPRQSMISTQNQYSTLSKPAALTGTLEVRLMGCQDILENVPGRSKATSVALPGWSPSETRSSFMSRTSKSKSGSSRNLLKTDDLSNDVCAVLKLDNTVVGQTSWKPISNQSWDQKFTLELDRSRELEISVYWRDWRSLCAVKFLRLEDFLDNQRHGMCLYLEPQGTLFAEVTFFNPVIERRPKLQRQKKIFSKQQGKTFLRAPQMNINIATWGRLVRRAIPTVNHSGTFSPQAPVPTTVPVVDVRIPQLAPPASDSTVTKLDFDLEPEPPPAPPRASSLGEIDESSELRVLDIPGQDSETVFDIQNDRNSILPKSQSEYKPDTPQSGLEYSGIQELEDRRSQQRFQFNLQDFRCCAVLGRGHFGKVLLAEYKNTNEMFAIKALKKGDIVARDEVDSLMCEKRIFETVNSVRHPFLVNLFACFQTKEHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEHKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSTEAISIMRRLLRRNPERRLGASEKDAEDVKKHPFFRLIDWSALMDKKVKPPFIPTIRGREDVSNFDDEFTSEAPILTPPREPRILSEEEQEMFRDFDYIADWC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASNPERGE ------CCCCCCCCC | 20.29 | - | |
3 | Phosphorylation | -----MASNPERGEI -----CCCCCCCCCE | 52.17 | 25159151 | |
10 (in isoform 4) | Phosphorylation | - | 4.21 | 22210691 | |
21 | Phosphorylation | ELQGDSRSLPFSENV EECCCCCCCCCCCCC | 44.33 | 30266825 | |
25 | Phosphorylation | DSRSLPFSENVSAVQ CCCCCCCCCCCCHHE | 26.73 | 30266825 | |
27 | Ubiquitination | RSLPFSENVSAVQKL CCCCCCCCCCHHEEC | 31.67 | 29967540 | |
29 | Phosphorylation | LPFSENVSAVQKLDF CCCCCCCCHHEECCC | 34.01 | 25159151 | |
39 | Phosphorylation | QKLDFSDTMVQQKLD EECCCCHHHHHHHHH | 20.31 | 28857561 | |
40 | Sulfoxidation | KLDFSDTMVQQKLDD ECCCCHHHHHHHHHH | 2.84 | 21406390 | |
44 | Ubiquitination | SDTMVQQKLDDIKDR CHHHHHHHHHHHHHH | 36.47 | 32015554 | |
58 | Acetylation | RIKREIRKELKIKEG HHHHHHHHHCCHHHH | 73.41 | 7266301 | |
59 | Ubiquitination | IKREIRKELKIKEGA HHHHHHHHCCHHHHH | 45.51 | 21963094 | |
77 | Acetylation | RKVTTDKKSLAYVDN HHHCCCHHHHHHHHH | 54.21 | 25953088 | |
77 | Ubiquitination | RKVTTDKKSLAYVDN HHHCCCHHHHHHHHH | 54.21 | 19413330 | |
78 | Phosphorylation | KVTTDKKSLAYVDNI HHCCCHHHHHHHHHH | 24.79 | 28152594 | |
81 | Phosphorylation | TDKKSLAYVDNILKK CCHHHHHHHHHHHHH | 17.40 | 28152594 | |
84 | Ubiquitination | KSLAYVDNILKKSNK HHHHHHHHHHHHCCH | 31.29 | 29967540 | |
90 | Ubiquitination | DNILKKSNKKLEELH HHHHHHCCHHHHHHH | 55.12 | 32015554 | |
110 | Phosphorylation | LNAHIVVSDPEDITD HCCCEEECCHHHCCC | 36.23 | 30266825 | |
110 | Ubiquitination | LNAHIVVSDPEDITD HCCCEEECCHHHCCC | 36.23 | 29967540 | |
115 | Ubiquitination | VVSDPEDITDCPRTP EECCHHHCCCCCCCC | 3.14 | 32015554 | |
116 | Phosphorylation | VSDPEDITDCPRTPD ECCHHHCCCCCCCCC | 43.82 | 30576142 | |
118 | Glutathionylation | DPEDITDCPRTPDTP CHHHCCCCCCCCCCC | 1.51 | 22555962 | |
121 | Phosphorylation | DITDCPRTPDTPNND HCCCCCCCCCCCCCC | 15.62 | 25159151 | |
124 | Phosphorylation | DCPRTPDTPNNDPRC CCCCCCCCCCCCCCC | 29.17 | 25159151 | |
127 | Ubiquitination | RTPDTPNNDPRCSTS CCCCCCCCCCCCCCC | 62.96 | 24816145 | |
143 | Ubiquitination | NRLKALQKQLDIELK HHHHHHHHHHCCEEH | 54.39 | - | |
162 | Phosphorylation | AENMIQMYSNGSSKD HHHHHHHHHCCCHHH | 5.21 | 20068231 | |
163 | Phosphorylation | ENMIQMYSNGSSKDR HHHHHHHHCCCHHHH | 29.40 | 25159151 | |
166 | Phosphorylation | IQMYSNGSSKDRKLH HHHHHCCCHHHHHHH | 38.16 | 20068231 | |
167 | Phosphorylation | QMYSNGSSKDRKLHG HHHHCCCHHHHHHHH | 39.72 | 25159151 | |
171 | Malonylation | NGSSKDRKLHGTAQQ CCCHHHHHHHHHHHH | 55.77 | 26320211 | |
171 | Ubiquitination | NGSSKDRKLHGTAQQ CCCHHHHHHHHHHHH | 55.77 | 29967540 | |
183 | Phosphorylation | AQQLLQDSKTKIEVI HHHHHHCCCHHHHHH | 29.30 | 20873877 | |
184 | Ubiquitination | QQLLQDSKTKIEVIR HHHHHCCCHHHHHHH | 63.23 | 29967540 | |
193 | Ubiquitination | KIEVIRMQILQAVQT HHHHHHHHHHHHHHC | 24.32 | 29967540 | |
228 | Ubiquitination | ELRHHFRIEFAVAEG HHHHHHHHHHHHHHH | 5.09 | 21963094 | |
239 | Ubiquitination | VAEGAKNVMKLLGSG HHHHHHHHHHHHCCC | 3.36 | 21963094 | |
241 | Ubiquitination | EGAKNVMKLLGSGKV HHHHHHHHHHCCCCC | 35.96 | 29967540 | |
247 | Acetylation | MKLLGSGKVTDRKAL HHHHCCCCCCCHHHH | 43.59 | 27452117 | |
247 | Ubiquitination | MKLLGSGKVTDRKAL HHHHCCCCCCCHHHH | 43.59 | 32015554 | |
253 | Ubiquitination | GKVTDRKALSEAQAR CCCCCHHHHHHHHHH | 19.74 | 29967540 | |
255 | Phosphorylation | VTDRKALSEAQARFN CCCHHHHHHHHHHHH | 35.43 | 20068231 | |
264 | Phosphorylation | AQARFNESSQKLDLL HHHHHHHHHHHHHHH | 38.89 | 20873877 | |
265 | Phosphorylation | QARFNESSQKLDLLK HHHHHHHHHHHHHHH | 25.75 | 28857561 | |
267 | 2-Hydroxyisobutyrylation | RFNESSQKLDLLKYS HHHHHHHHHHHHHHH | 46.01 | - | |
267 | Ubiquitination | RFNESSQKLDLLKYS HHHHHHHHHHHHHHH | 46.01 | 29967540 | |
272 | Acetylation | SQKLDLLKYSLEQRL HHHHHHHHHHHHHHH | 39.84 | 20167786 | |
272 | Ubiquitination | SQKLDLLKYSLEQRL HHHHHHHHHHHHHHH | 39.84 | 32015554 | |
273 | Phosphorylation | QKLDLLKYSLEQRLN HHHHHHHHHHHHHHH | 20.61 | 17494752 | |
274 | Phosphorylation | KLDLLKYSLEQRLNE HHHHHHHHHHHHHHH | 24.68 | 17494752 | |
284 | Ubiquitination | QRLNEVPKNHPKSRI HHHHHCCCCCCCCCE | 73.41 | 24816145 | |
289 | Phosphorylation | VPKNHPKSRIIIEEL CCCCCCCCCEEEEEH | 32.91 | 20068231 | |
297 | Phosphorylation | RIIIEELSLVAASPT CEEEEEHHHHHCCCC | 24.87 | 20873877 | |
302 | Phosphorylation | ELSLVAASPTLSPRQ EHHHHHCCCCCCHHH | 14.53 | 29255136 | |
304 | Phosphorylation | SLVAASPTLSPRQSM HHHHCCCCCCHHHHH | 37.06 | 30266825 | |
306 | Phosphorylation | VAASPTLSPRQSMIS HHCCCCCCHHHHHCC | 22.10 | 30266825 | |
310 | Phosphorylation | PTLSPRQSMISTQNQ CCCCHHHHHCCCCCH | 21.26 | 30576142 | |
313 | Phosphorylation | SPRQSMISTQNQYST CHHHHHCCCCCHHHC | 18.46 | 29449344 | |
314 | Phosphorylation | PRQSMISTQNQYSTL HHHHHCCCCCHHHCC | 22.18 | 29449344 | |
318 | Phosphorylation | MISTQNQYSTLSKPA HCCCCCHHHCCCCCC | 15.92 | 23917254 | |
323 | Ubiquitination | NQYSTLSKPAALTGT CHHHCCCCCCHHCCC | 41.61 | - | |
338 | Glutathionylation | LEVRLMGCQDILENV EEEEEECHHHHHHCC | 1.73 | 22555962 | |
345 | Ubiquitination | CQDILENVPGRSKAT HHHHHHCCCCCCCCC | 3.77 | 32015554 | |
349 | Phosphorylation | LENVPGRSKATSVAL HHCCCCCCCCCEEEC | 32.34 | - | |
350 | Ubiquitination | ENVPGRSKATSVALP HCCCCCCCCCEEECC | 55.08 | 29967540 | |
352 | Phosphorylation | VPGRSKATSVALPGW CCCCCCCCEEECCCC | 27.72 | 23403867 | |
353 | Phosphorylation | PGRSKATSVALPGWS CCCCCCCEEECCCCC | 15.39 | 23403867 | |
360 | Phosphorylation | SVALPGWSPSETRSS EEECCCCCCHHHHHH | 25.18 | 19664994 | |
360 (in isoform 2) | Phosphorylation | - | 25.18 | 25159151 | |
362 | Phosphorylation | ALPGWSPSETRSSFM ECCCCCCHHHHHHHH | 46.19 | 25159151 | |
362 (in isoform 2) | Phosphorylation | - | 46.19 | 25159151 | |
364 | Phosphorylation | PGWSPSETRSSFMSR CCCCCHHHHHHHHHC | 39.94 | 25159151 | |
364 (in isoform 2) | Phosphorylation | - | 39.94 | 25159151 | |
366 | Phosphorylation | WSPSETRSSFMSRTS CCCHHHHHHHHHCCC | 35.03 | 25159151 | |
366 (in isoform 2) | Phosphorylation | - | 35.03 | 25159151 | |
367 | Phosphorylation | SPSETRSSFMSRTSK CCHHHHHHHHHCCCC | 22.98 | 25159151 | |
367 (in isoform 2) | Phosphorylation | - | 22.98 | 25159151 | |
370 | Phosphorylation | ETRSSFMSRTSKSKS HHHHHHHHCCCCCCC | 30.32 | 25159151 | |
370 (in isoform 2) | Phosphorylation | - | 30.32 | 25159151 | |
372 | Phosphorylation | RSSFMSRTSKSKSGS HHHHHHCCCCCCCCC | 32.95 | 29514088 | |
373 | Phosphorylation | SSFMSRTSKSKSGSS HHHHHCCCCCCCCCC | 33.55 | 29514088 | |
374 | Ubiquitination | SFMSRTSKSKSGSSR HHHHCCCCCCCCCCC | 62.38 | 29967540 | |
375 | Phosphorylation | FMSRTSKSKSGSSRN HHHCCCCCCCCCCCC | 31.64 | 29038488 | |
376 | Methylation | MSRTSKSKSGSSRNL HHCCCCCCCCCCCCC | 63.67 | 116252779 | |
377 | Phosphorylation | SRTSKSKSGSSRNLL HCCCCCCCCCCCCCC | 51.50 | 29038488 | |
379 | Phosphorylation | TSKSKSGSSRNLLKT CCCCCCCCCCCCCCC | 32.96 | 25159151 | |
380 | Phosphorylation | SKSKSGSSRNLLKTD CCCCCCCCCCCCCCC | 28.81 | 29038488 | |
385 | Ubiquitination | GSSRNLLKTDDLSND CCCCCCCCCCCCCCC | 53.74 | 21963094 | |
394 | Ubiquitination | DDLSNDVCAVLKLDN CCCCCCEEEEEEECC | 2.12 | 29967540 | |
402 | Phosphorylation | AVLKLDNTVVGQTSW EEEEECCCEEEEECC | 19.08 | 20873877 | |
407 | Phosphorylation | DNTVVGQTSWKPISN CCCEEEEECCEECCC | 30.53 | 20873877 | |
408 | Phosphorylation | NTVVGQTSWKPISNQ CCEEEEECCEECCCC | 25.80 | 20873877 | |
408 | Ubiquitination | NTVVGQTSWKPISNQ CCEEEEECCEECCCC | 25.80 | 21963094 | |
410 | Ubiquitination | VVGQTSWKPISNQSW EEEEECCEECCCCCC | 32.04 | 29967540 | |
413 | Phosphorylation | QTSWKPISNQSWDQK EECCEECCCCCCCCE | 37.03 | 20873877 | |
416 | Phosphorylation | WKPISNQSWDQKFTL CEECCCCCCCCEEEE | 36.55 | 20873877 | |
426 | Phosphorylation | QKFTLELDRSRELEI CEEEEEECCCCEEEE | 36.81 | 32142685 | |
428 | Phosphorylation | FTLELDRSRELEISV EEEEECCCCEEEEEE | 29.76 | 26091039 | |
454 | Ubiquitination | KFLRLEDFLDNQRHG EEEEHHHHHHCCCCE | 7.24 | 32015554 | |
458 | Ubiquitination | LEDFLDNQRHGMCLY HHHHHHCCCCEEEEE | 38.11 | 22817900 | |
462 | Ubiquitination | LDNQRHGMCLYLEPQ HHCCCCEEEEEECCC | 0.86 | 29967540 | |
468 | Ubiquitination | GMCLYLEPQGTLFAE EEEEEECCCCEEEEE | 34.99 | 29967540 | |
486 | Ubiquitination | FNPVIERRPKLQRQK CCHHHHCCHHHHHHH | 21.66 | 32015554 | |
497 | Phosphorylation | QRQKKIFSKQQGKTF HHHHHHHHHHCCCCH | 32.78 | 23401153 | |
498 | Ubiquitination | RQKKIFSKQQGKTFL HHHHHHHHHCCCCHH | 35.57 | - | |
501 | Ubiquitination | KIFSKQQGKTFLRAP HHHHHHCCCCHHCCC | 28.60 | 21963094 | |
502 | Ubiquitination | IFSKQQGKTFLRAPQ HHHHHCCCCHHCCCC | 31.59 | 32015554 | |
503 | Phosphorylation | FSKQQGKTFLRAPQM HHHHCCCCHHCCCCC | 34.42 | 27251275 | |
503 | Ubiquitination | FSKQQGKTFLRAPQM HHHHCCCCHHCCCCC | 34.42 | 21963094 | |
516 | Phosphorylation | QMNINIATWGRLVRR CCCEEHHHHHHHHHH | 25.34 | 30576142 | |
517 | Ubiquitination | MNINIATWGRLVRRA CCEEHHHHHHHHHHH | 4.85 | 21963094 | |
520 | Ubiquitination | NIATWGRLVRRAIPT EHHHHHHHHHHHCCC | 2.87 | 29967540 | |
527 | Phosphorylation | LVRRAIPTVNHSGTF HHHHHCCCCCCCCCC | 28.03 | 28176443 | |
531 | Phosphorylation | AIPTVNHSGTFSPQA HCCCCCCCCCCCCCC | 34.03 | 30266825 | |
533 | Phosphorylation | PTVNHSGTFSPQAPV CCCCCCCCCCCCCCC | 24.77 | 30266825 | |
535 | Phosphorylation | VNHSGTFSPQAPVPT CCCCCCCCCCCCCCC | 18.88 | 30266825 | |
542 | Phosphorylation | SPQAPVPTTVPVVDV CCCCCCCCCCEEEEE | 40.43 | 24732914 | |
543 | Phosphorylation | PQAPVPTTVPVVDVR CCCCCCCCCEEEEEE | 19.42 | 24732914 | |
549 | Ubiquitination | TTVPVVDVRIPQLAP CCCEEEEEECCCCCC | 3.95 | 21963094 | |
559 | Phosphorylation | PQLAPPASDSTVTKL CCCCCCCCCCCCEEE | 37.56 | 15822905 | |
561 | Phosphorylation | LAPPASDSTVTKLDF CCCCCCCCCCEEECC | 23.45 | 15822905 | |
562 | Phosphorylation | APPASDSTVTKLDFD CCCCCCCCCEEECCC | 36.87 | 23828894 | |
564 | Phosphorylation | PASDSTVTKLDFDLE CCCCCCCEEECCCCC | 26.44 | 26074081 | |
565 | Ubiquitination | ASDSTVTKLDFDLEP CCCCCCEEECCCCCC | 41.54 | 21963094 | |
567 | Phosphorylation | DSTVTKLDFDLEPEP CCCCEEECCCCCCCC | 36.25 | 32142685 | |
571 | Ubiquitination | TKLDFDLEPEPPPAP EEECCCCCCCCCCCC | 49.84 | 29967540 | |
577 | Ubiquitination | LEPEPPPAPPRASSL CCCCCCCCCCCCCCC | 32.29 | 29967540 | |
582 | Phosphorylation | PPAPPRASSLGEIDE CCCCCCCCCCCCCCC | 27.63 | 29255136 | |
583 | Phosphorylation | PAPPRASSLGEIDES CCCCCCCCCCCCCCC | 39.13 | 29255136 | |
590 | Phosphorylation | SLGEIDESSELRVLD CCCCCCCCCCEEEEE | 25.93 | 25159151 | |
591 | Phosphorylation | LGEIDESSELRVLDI CCCCCCCCCEEEEEC | 38.31 | 23927012 | |
603 | Phosphorylation | LDIPGQDSETVFDIQ EECCCCCCCEEEEEC | 27.55 | 20873877 | |
603 | Ubiquitination | LDIPGQDSETVFDIQ EECCCCCCCEEEEEC | 27.55 | 29967540 | |
604 | Ubiquitination | DIPGQDSETVFDIQN ECCCCCCCEEEEECC | 58.23 | 27667366 | |
605 | Phosphorylation | IPGQDSETVFDIQND CCCCCCCEEEEECCC | 30.35 | 29978859 | |
609 | Ubiquitination | DSETVFDIQNDRNSI CCCEEEEECCCCCCC | 2.54 | 29967540 | |
613 | Methylation | VFDIQNDRNSILPKS EEEECCCCCCCCCCC | 46.47 | 115487703 | |
615 | Phosphorylation | DIQNDRNSILPKSQS EECCCCCCCCCCCCC | 26.79 | 20068231 | |
619 | Ubiquitination | DRNSILPKSQSEYKP CCCCCCCCCCCCCCC | 58.65 | 29967540 | |
620 | Phosphorylation | RNSILPKSQSEYKPD CCCCCCCCCCCCCCC | 36.68 | 29978859 | |
622 | Phosphorylation | SILPKSQSEYKPDTP CCCCCCCCCCCCCCC | 50.40 | 29978859 | |
624 | Phosphorylation | LPKSQSEYKPDTPQS CCCCCCCCCCCCCCC | 32.82 | 28796482 | |
625 | Ubiquitination | PKSQSEYKPDTPQSG CCCCCCCCCCCCCCC | 32.16 | 29967540 | |
627 | Ubiquitination | SQSEYKPDTPQSGLE CCCCCCCCCCCCCCC | 67.86 | 22817900 | |
628 | Phosphorylation | QSEYKPDTPQSGLEY CCCCCCCCCCCCCCC | 31.58 | 25159151 | |
629 | Ubiquitination | SEYKPDTPQSGLEYS CCCCCCCCCCCCCCC | 33.45 | 29967540 | |
631 | Phosphorylation | YKPDTPQSGLEYSGI CCCCCCCCCCCCCCC | 46.69 | 30175587 | |
635 | Phosphorylation | TPQSGLEYSGIQELE CCCCCCCCCCCHHHH | 19.76 | 21712546 | |
636 | Phosphorylation | PQSGLEYSGIQELED CCCCCCCCCCHHHHH | 21.75 | 21712546 | |
646 | Phosphorylation | QELEDRRSQQRFQFN HHHHHHHHHHCCEEC | 31.40 | 30576142 | |
658 | Phosphorylation | QFNLQDFRCCAVLGR EECCHHHHHHEEECC | 23.93 | 32142685 | |
658 | Ubiquitination | QFNLQDFRCCAVLGR EECCHHHHHHEEECC | 23.93 | 29901268 | |
659 | Phosphorylation | FNLQDFRCCAVLGRG ECCHHHHHHEEECCC | 1.44 | 32142685 | |
661 | Ubiquitination | LQDFRCCAVLGRGHF CHHHHHHEEECCCCC | 11.82 | 29967540 | |
663 | Phosphorylation | DFRCCAVLGRGHFGK HHHHHEEECCCCCHH | 1.74 | 32142685 | |
676 | Phosphorylation | GKVLLAEYKNTNEMF HHHEEEECCCCCCCC | 12.16 | 28102081 | |
677 | Ubiquitination | KVLLAEYKNTNEMFA HHEEEECCCCCCCCH | 49.12 | 29967540 | |
686 | Acetylation | TNEMFAIKALKKGDI CCCCCHHHHHHHCCE | 44.21 | 19820183 | |
690 | Ubiquitination | FAIKALKKGDIVARD CHHHHHHHCCEEEHH | 63.77 | 29901268 | |
701 | Phosphorylation | VARDEVDSLMCEKRI EEHHHHHHHHHHHHH | 24.15 | 30576142 | |
706 | 2-Hydroxyisobutyrylation | VDSLMCEKRIFETVN HHHHHHHHHHHHHHH | 45.96 | - | |
706 | Acetylation | VDSLMCEKRIFETVN HHHHHHHHHHHHHHH | 45.96 | 26051181 | |
706 | Ubiquitination | VDSLMCEKRIFETVN HHHHHHHHHHHHHHH | 45.96 | 29901268 | |
720 | Ubiquitination | NSVRHPFLVNLFACF HHCCCCHHHHHHHHC | 2.69 | 22817900 | |
722 | Ubiquitination | VRHPFLVNLFACFQT CCCCHHHHHHHHCCC | 31.43 | 22817900 | |
729 | Phosphorylation | NLFACFQTKEHVCFV HHHHHCCCCCEEEEE | 20.39 | 24719451 | |
736 | Ubiquitination | TKEHVCFVMEYAAGG CCCEEEEEEEECCCC | 2.11 | 22817900 | |
767 | Phosphorylation | VFYAACVVLGLQYLH HHHHHHHHHHHHHHH | 3.36 | 32142685 | |
768 | Phosphorylation | FYAACVVLGLQYLHE HHHHHHHHHHHHHHH | 2.56 | 32142685 | |
768 | Ubiquitination | FYAACVVLGLQYLHE HHHHHHHHHHHHHHH | 2.56 | 22817900 | |
771 | Ubiquitination | ACVVLGLQYLHEHKI HHHHHHHHHHHHCCE | 36.62 | 29967540 | |
772 | Phosphorylation | CVVLGLQYLHEHKIV HHHHHHHHHHHCCEE | 18.31 | 32142685 | |
773 | Ubiquitination | VVLGLQYLHEHKIVY HHHHHHHHHHCCEEE | 2.17 | 32015554 | |
784 | Ubiquitination | KIVYRDLKLDNLLLD CEEECCCCCCCEEEC | 59.07 | 21906983 | |
792 | Phosphorylation | LDNLLLDTEGFVKIA CCCEEECCCCCEEHH | 37.67 | 27251275 | |
799 | Phosphorylation | TEGFVKIADFGLCKE CCCCEEHHHCCCCCC | 10.60 | 32142685 | |
800 | Phosphorylation | EGFVKIADFGLCKEG CCCEEHHHCCCCCCC | 41.44 | 32142685 | |
801 | Phosphorylation | GFVKIADFGLCKEGM CCEEHHHCCCCCCCC | 6.26 | 32645325 | |
804 | Phosphorylation | KIADFGLCKEGMGYG EHHHCCCCCCCCCCC | 3.74 | 32142685 | |
805 | Ubiquitination | IADFGLCKEGMGYGD HHHCCCCCCCCCCCC | 63.45 | - | |
810 | Phosphorylation | LCKEGMGYGDRTSTF CCCCCCCCCCCCCCC | 13.63 | 22322096 | |
814 | Phosphorylation | GMGYGDRTSTFCGTP CCCCCCCCCCCCCCC | 36.54 | 22322096 | |
815 | Phosphorylation | MGYGDRTSTFCGTPE CCCCCCCCCCCCCCC | 22.00 | 22322096 | |
816 | Phosphorylation | GYGDRTSTFCGTPEF CCCCCCCCCCCCCCC | 23.49 | 22322096 | |
820 | Phosphorylation | RTSTFCGTPEFLAPE CCCCCCCCCCCCCHH | 22.33 | 21712546 | |
832 | Phosphorylation | APEVLTETSYTRAVD CHHHHCCCCCCCCHH | 23.07 | 28985074 | |
834 | Phosphorylation | EVLTETSYTRAVDWW HHHCCCCCCCCHHHH | 13.99 | 28985074 | |
866 | Ubiquitination | GDDEEEVFDSIVNDE CCCHHHHHHHHHCCC | 7.44 | 27667366 | |
868 | Ubiquitination | DEEEVFDSIVNDEVR CHHHHHHHHHCCCCC | 19.57 | 27667366 | |
880 | Ubiquitination | EVRYPRFLSTEAISI CCCCCCCCCHHHHHH | 6.99 | 29967540 | |
882 | Phosphorylation | RYPRFLSTEAISIMR CCCCCCCHHHHHHHH | 31.42 | 20860994 | |
882 | Ubiquitination | RYPRFLSTEAISIMR CCCCCCCHHHHHHHH | 31.42 | 32015554 | |
903 | Phosphorylation | PERRLGASEKDAEDV HHHCCCCCCCCHHHH | 43.30 | 23403867 | |
910 | Phosphorylation | SEKDAEDVKKHPFFR CCCCHHHHHHCCHHH | 7.19 | 32645325 | |
912 | Ubiquitination | KDAEDVKKHPFFRLI CCHHHHHHCCHHHCC | 57.25 | 29967540 | |
914 | Ubiquitination | AEDVKKHPFFRLIDW HHHHHHCCHHHCCCH | 38.66 | 32015554 | |
928 | Ubiquitination | WSALMDKKVKPPFIP HHHHCCCCCCCCCCC | 51.75 | 29967540 | |
930 | Ubiquitination | ALMDKKVKPPFIPTI HHCCCCCCCCCCCCC | 56.72 | 32015554 | |
942 | Phosphorylation | PTIRGREDVSNFDDE CCCCCCCCCCCCCCC | 48.02 | 32645325 | |
944 | Phosphorylation | IRGREDVSNFDDEFT CCCCCCCCCCCCCCC | 44.06 | 20873877 | |
951 | Phosphorylation | SNFDDEFTSEAPILT CCCCCCCCCCCCCCC | 24.49 | 23927012 | |
952 | Phosphorylation | NFDDEFTSEAPILTP CCCCCCCCCCCCCCC | 36.76 | 22167270 | |
958 | Phosphorylation | TSEAPILTPPREPRI CCCCCCCCCCCCCCC | 31.78 | 29255136 | |
967 | Phosphorylation | PREPRILSEEEQEMF CCCCCCCCHHHHHHH | 40.36 | 26074081 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PKN2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PKN2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-360 AND SER-583, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582; SER-583 ANDTHR-814, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-360 AND SER-583, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110; THR-121; THR-124;SER-302; SER-306; SER-360; SER-362; SER-535; THR-628; SER-631 ANDTHR-958, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-306; SER-360;SER-535; SER-583 AND THR-958, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-360; SER-531 ANDSER-535, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-531 AND SER-535, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-306 ANDSER-360, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289; SER-583 ANDTHR-958, AND MASS SPECTROMETRY. | |
"Phosphoproteomic analysis of synaptosomes from human cerebralcortex."; DeGiorgis J.A., Jaffe H., Moreira J.E., Carlotti C.G. Jr., Leite J.P.,Pant H.C., Dosemeci A.; J. Proteome Res. 4:306-315(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-559 AND SER-561, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582 AND THR-816, ANDMASS SPECTROMETRY. | |
"Phosphorylation of protein kinase N by phosphoinositide-dependentprotein kinase-1 mediates insulin signals to the actin cytoskeleton."; Dong L.Q., Landa L.R., Wick M.J., Zhu L., Mukai H., Ono Y., Liu F.; Proc. Natl. Acad. Sci. U.S.A. 97:5089-5094(2000). Cited for: PHOSPHORYLATION AT THR-816 BY PDPK1, AND INTERACTION WITH PDPK1. |